Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07563179 · RECRUITING
Trial details
- NCT number
- NCT07563179
- Sponsor
- Shenzhen University General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2029-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.